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MembraneThe interaction of amyloid β-peptide (Aβ) with cell membranes is believed to play a central role in the
pathogenesis of Alzheimer's disease. In particular, recent experimental evidence indicates that bilayer and
monolayer membranes accelerate the aggregation and amyloid ﬁbril formation rate of Aβ. Understanding that
interaction could help develop therapeutic strategies for treatment of the disease. Trehalose, a disaccharide of
glucose, has been shown to be effective in preventing the aggregation of numerous proteins. It has also been
shown to delay the onset of certain amyloid-related diseases in a mouse model. Using Langmuir monolayers
andmolecular simulations of the corresponding system, we study several thermodynamic and kinetic aspects
of the insertion of Aβ peptide into DPPGmonolayers in water and trehalose subphases. In the water subphase,
the insertion of the Aβ peptide into the monolayer exhibits a lag time which decreases with increasing
temperature of the subphase. In the presence of trehalose, the lag time is completely eliminated and peptide
insertion is completed within a shorter time period compared to that observed in pure water. Molecular
simulations show that more peptide is inserted into the monolayer in the water subphase, and that such
insertion is deeper. The peptide at the monolayer interface orients itself parallel to the monolayer, while it
inserts with an angle of 50° in the trehalose subphase. Simulations also show that trehalose reduces the
conformational change that the peptide undergoes when it inserts into the monolayer. This observation helps
explain the experimentally observed elimination of the lag time by trehalose and the temperature
dependence of the lag time in the water subphase.1 608 262 5434.
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Alzheimer's disease is associated with the formation of amyloid
deposits generated by the polymerization of amyloidogenic Amyloid
β-peptide (Aβ) [1,2]. Aβ peptide is an amphipathic molecule that is
formed by proteolytical cleavage of the transmembrane amyloid
precursor protein (APP) and is soluble in the plasma and cerebral
vascular ﬂuids [3,4]. The formation of ﬁbrillar amyloid deposits is
accompanied by conformational changes of the soluble peptide in
the random coil or α-helical structure into β-sheet structures [5,6].
This is a nucleation dependent process where ﬁbrillogenesis is
facilitated by the formation of small amounts of aggregates. Lipid
membranes have been studied as templates that facilitate the
formation of the seeds for nucleation [7,8]. It has been shown that
in the presence of lipid membranes, Aβ changes its conﬁguration from
a random coil to a beta-sheet or an alpha-helix [9–11] and the rate ofaggregation is increased by three orders of magnitude [10,12]. The
presence of additional components, such as gangliosides has been
shown to accelerate the beta-sheet formation and aggregation
processes [13].
Membrane model systems, such as monolayers, vesicles and
supported bilayers have been utilized to study the effect of lipids on
the structure of the peptide [14–18] and the effect of the peptide in
the disruption of the lipid membranes [19–23]. In particular, Ege
and Lee studied the insertion of Aβ into anionic (DPPG), cationic
(DPTAP) and zwitterionic (DPPC) lipids and showed that insertion
occurs mainly into anionic lipid membranes. They also performed
dual-probe ﬂuorescence measurements of the lipid and the peptide
to study the surface morphology of the membranes and found that
the peptide inserts into the expanded domains of the lipid
membrane [24]. Kawasaki and coworkers studied the binding and
adsorption of peptide aggregates on monolayers [25]. Grazing
incidence X-ray diffraction and infrared reﬂection absorption
spectroscopy measurements showed that Aβ absorbs into zwitter-
ionic and anionic lipid monolayers in the uncompressed state
adopting a β-sheet conﬁguration [14,26]. More recently Chi and
coworkers studied the effect of salts, pH and lipid charge on the
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the presence of vesicles [27]. The effects of temperature and surface
pressure on the kinetics of Aβ insertion into monolayers, however,
do not appear to have been analyzed before. Kinetic information on
Aβ insertion into lipidic interfaces could provide valuable insights
into the process of ﬁbril formation.
Several strategies have been considered to prevent or reduce Aβ
aggregation. A variety of molecules have been considered as inhibitors
of amyloid aggregation [28–33]. More recently, structural studies
have been used to pursue the design of inhibitor molecules [34]. In
particular, recent experiments indicate that, in bulk solutions,
trehalose, a disaccharide of glucose, inhibits the aggregation of
Aβ(1–40) and (1–42) [35,36]. Trehalose has also been proven to
inhibit the aggregation of other amyloidogenic peptides in solution,
including insulin [37] and polyglutamine peptides [38]. In the context
of Huntington disease, trehalose has been shown to prevent the onset
of the disease in a mouse model [38]. In a different context, trehalose
is often used as an additive during lyophilization of proteins and cells,
where it prevents damage to biological structures through a
combination of direct and indirect interactions. Trehalose has been
shown to interact with the phospholipid head groups of bilayer
membranes [39] and has often been used as a cryoprotectant [40,41].
Recent molecular simulations of a fragment of Aβ, namely Aβ(29–40),
in water and trehalose subphases have shown that in pure water the
free energy of the peptide exhibits a broad minimum around
disordered conformations, while in a trehalose subphase the α-
helical conformation has a lower free energy [42]. Simulations have
also shown that the peptide inserts into the DPPC bilayers in the α-
helical conﬁguration.
In this work, the effect of trehalose on the insertion of Aβ(1–40)
into anionic DPPG monolayers at different temperatures and surface
pressures is studied experimentally. Molecular simulations are also
performed to analyze the effect of trehalose on the secondary
structure of full Aβ and the free energy of the peptide during insertion
into a monolayer. The mechanism of Aβ insertion into the monolayer
and the role of trehalose on the dynamics of insertion are discussed.2. Experimental methods
2.1. Materials
Synthetic β-Amyloid(1–40) was purchased from Anaspec (San
Jose, CA). Stock solutions were prepared by dissolving the peptide
in DMSO to reach a ﬁnal concentration of 1 mg/ml. 1,2-Dipalmitoyl-sn-
Glycero-3-[Phospho-rac-1-glycerol]sodium salt (DPPG) was purchased
from Avanti Polar Lipids (Albaster, AL). Trehalose was purchased from
Ferro Pfanstiehl Laboratories (Waukegan, IL).2.2. Preparation of the monolayer
The surface pressure–area isotherms were obtained by means of a
computer-controlled Langmuir Teﬂon-coated trough (KSV Minimicro
System 1S, Helsinki, Finland) with a total surface area of 100 cm2. The
surface pressure was measured following a Wilhelmy-plate method
using a roughened platinum plate connected to a microelectronic
feedback system. Before starting the experiment, the trough was
cleaned successively with ethanol and ultrapure deionized water. The
trough was ﬁlled up with water and surface active impurities were
removed by simultaneous sweeping and suction of the interface. The
trough was thermostated using a water circulating bath. Monolayers
were prepared by spreading the lipid solution on the aqueous
subphase (pure water or 100 mM trehalose solution) using a
Hamilton syringe. An equilibration time of 20 min was allowed before
compressing the monolayer at 5 mm/min.2.3. Constant pressure experiments
A constant surface pressure assay was used to monitor the
insertion of the amyloid peptide in the DPPG monolayers. Experi-
ments were performed by spreading DPPG onto a subphase free of
peptide, and then compressing the lipid ﬁlm to the predetermined
surface pressure (25 mN/m or 30 mN/m). These pressure values were
chosen to be close to the lipid-packing density of a bilayer [43] which
is roughly equal to that of a monolayer at around 30 mN/m. Once the
desired surface pressure was reached, it was kept constant. Fifty
microliters of 1 mg/ml Aβ40 in DMSO was then aliquoted out, topped
off with 0.2 ml water, and immediately injected into the subphase
(50 ml) through an injection port using a syringe (Hamilton, Reno,
NV). We have chosen to solubilize the peptide in DMSO because low
concentrations of DMSO have been shown to have only a slight effect
on phospholipid structure [44,45]. In contrast, recent experiments
using HFIP, which is often used to solubilize Aβ, show that it
accelerates the aggregation of amyloid peptides [46]. After peptide
injection, the area was recorded along time. In this constant-pressure
mode, insertion of the peptide into the lipid leads to an increase in the
lipid surface area. The effect of temperature was examined in a range
between 20 °C and 35 °C±1 °C using a water bath.
3. Computational methods
The simulated system, shown in Fig. 1, includes twomonolayers of
DPPG, with periodic boundary conditions, separated on one side by
solvent and on the other side by vacuum. The initial structure of the
Aβ(1–40) peptide was taken from a recent report obtained for
implicit-membrane simulations [47]. That structure consists of twoα-
helical regions and two random coil regions. The monolayer
membrane considered in this work included 64 DPPG molecules.
The entire systemwas simulated using the Gromos96 53a6 force ﬁeld,
which has been shown to work well in lipid environments [48]. All
simulations were performed at 300 K.
The initial structure of the monolayer was obtained by starting
with an equilibrated DPPC bilayer generated in previous computa-
tional studies [39,49]. That structure was modiﬁed into a DPPG
monolayer, and was then equilibrated for 10 ns, at which point the
energy and structural characteristics were observed to converge.
Initial structures for the system consisting of both the peptide and the
monolayer were obtained by ﬁrst running a series of expansions and
energy minimizations of the membrane, then inserting the peptide,
minimizing the energy, removing the peptide, contracting the system,
and repeating the insertion until an appropriate lipid density was
obtained, as described in by Kandt et al. [50]. As mentioned above, the
full simulation box included two monolayers, one in the positive and
one in the negative z-direction (normal to the monolayer) from the
center of the box. The size of the simulation box was 5.14×5.14 nm in
the x–y plane, while the total distance in the z-direction was
approximately 8 nm, including the vacuum region.
Two different solvent systems were studied in this work: (a) pure
water and (b) a 30%w/w trehalose/water mixture. Water molecules
were modeled using the simple point charge (SPC) model [51]. For
consistency, trehalose was also modeled using the Gromos 53a6 force
ﬁeld. Our simulations were performed with the Gromacs molecular
simulation package [52]. Long-range electrostatic interactions were
treated with a particle-mesh Ewald sum. The simulations were
performed with rigid bonds (using the linear constraint solver
method [53]) and with an integration time step of 2 fs. Multiple
replicas of the system were set up with different distances in the z-
direction between the center of mass of the peptide and the center of
mass of the membrane. The range of distances varied such that at one
extreme the peptide was 2 nm away from the center, on the solvent
side, and at the other extreme it was 0.3 nm from the center, on the
side closer to the vacuum region. Replicas were placed at regular
Fig. 1. Representative conﬁguration of the simulation box. Along the z-axis, there are twomonolayers of DPPG separated on one side by solvent and on the other side by vacuum. The
x and y axes are periodic. The snapshot was rendered using visual molecular dynamics (VMD) [70].
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strained in each replica and the force necessary to enforce this
constraint was recorded. The system was simulated for 15 ns, and the
ﬁrst 4 ns of simulation time were excluded from the analysis to allow
for equilibration. The mean force at each separation was determined
and integrated to obtain a potential of mean force (PMF).
4. Results
Fig. 2 shows experimental data for the change in area as a function
of time for a DPPG ﬁlm spread on pure water at different
temperatures. The DPPG monolayer was compressed up to 25 mN/
m (Fig. 2a) and 30 mN/m (Fig. 2b), after which a constant-pressure
experiment was performed. At these pressures, the monolayer is in
the “liquid” or condensed branch of the pressure isotherms (see
Fig. 3). The Aβ peptide was injected into the subphase and the area
was recorded as a function of time to follow the peptide insertion. The
constant-pressure curves exhibit a sigmoid shape consisting of a lag
time and a growth phase. The increase in temperature causes a larger
increase in the area. The area change is about three times larger for the
monolayer compressed at 25 mN/m (Fig. 2a) than that at 30 mN/m
(Fig. 2b). Also, at 30 mN/m, it is observed that the curves tend to reach
saturation at lower areas than those compressed at 25 mN/m. This is
consistent with the results of Terzi and coworkers [10], who reported
that no insertion of peptide occurred at high surface pressures. In
general, the results in Fig. 2 are consistent with those presented by
Ege and Lee for the same system [24] and, as such, serve to validate
our experimental methods and procedures.
It has been reported that the conformation of the Aβ in aqueous
solution is predominantly random coil [54,55]. Experimental evidence
suggests that, in order to insert into the monolayer, the peptide needsto adopt anα-helical structure [55–57]. Accordingly, upon injection of
the peptide into the water subphase, the peptide would have to
undergo a transition from a random coil to an α-helix prior to
insertion into the monolayer. The time required for this transition
could partly account for the observed lag time. Such conformational
transitions are likely to be affected by temperature: it is observed that
the lag time decreases with increasing temperature, but it is not
altered to the same extent by the surface pressure of the monolayer
(Fig. 2c). This last statement has been substantiated by constant-
pressure experiments for 10 to 30 mN/m surface pressures at 30 °C
(data not shown), which do not reveal a signiﬁcant variation in the lag
times. Given these results, it is proposed that, up to a pressure of
30 mN/m, the degree of compression of the monolayer is not a
limiting step for peptide insertion.
To study the effect of trehalose on the interaction of Aβ with the
DPPG monolayers, the insertion experiments were performed with a
100 mM trehalose subphase at 25 mN/m and 30 mN/m surface
pressure and compared with the ones in a pure water subphase.
Fig. 3a shows the compression isotherms for DPPG monolayers at
30 °C on water and 100 mM trehalose subphases. At a given pressure,
the area density of the DPPGmonolayer in the presence of trehalose is
approximately 5 Å2/molecule larger than in pure water. This obser-
vation is consistent with previous experimental observations [58].
Fig. 3b shows area versus time curves for DPPG ﬁlms spread on a
100 mM trehalose solution at a surface pressure of 25 mN/m. The
curves exhibit an exponential growth behavior, which differs
considerably from the sigmoid shape observed in the pure water
subphase (Fig. 2a). Furthermore, in the presence of trehalose, the
kinetics of peptide insertion is not signiﬁcantly affected by temper-
ature. For all samples, the maximum area increase was reached 1 h
after the peptide injection (Fig. 3b). In pure water (Fig. 2a), isotherms
Fig. 2. Percent area change versus time curves of a DPPG ﬁlm at constant surface
pressure of (a) 25 mN/m and (b) 30 mN/m after injection of Aβ into thewater subphase
at time zero. (c) The lag time before insertion of Aβ into the DPPG monolayer begins
versus temperature for 25 mN/m and 30 mN/m surface pressures of the monolayer.
Fig. 3. (a) Compression isotherms of DPPG on water and 100 mM trehalose subphases.
(b) Percent area change versus time curves of a DPPG ﬁlm at constant surface pressure
of 25 mN/m after injection of Aβ into 100 mM trehalose subphase at time zero.
(c) Same as (b), but at a surface pressure of 30 mN/m.
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and none of the samples at 25 mN/m display a plateau during the time
scale of our experiments. Fig. 3c shows the area increase versus time
curves in 100 mM trehalose solution at 30 mN/m surface pressure.
The extent of insertion is 10 times lower at this surface pressure and it
is not affected by temperature. Note that, while the membranes are
more expanded in the presence of trehalose, the actual terminal
degree of expansion of the monolayer (the plateau region of Figs. 3b
and c) is much smaller in trehalose than in pure water.
The compression isotherms of DPPG (Fig. 3a) show that at 25 mN/
m surface pressure, the monolayer is 5 Å2/molecule more expandedon the trehalose subphase. Fig. 4 shows the insertion of Aβ on the
water subphase at 11 mN/m surface pressure, where the area per lipid
molecule corresponds to the one at 25 mN/m on the trehalose
subphase. The lag time before the peptide starts inserting into the
monolayer is not affected by the expansion of the monolayer on
the water subphase and the reduction of the surface pressure; only
the rate and amount of insertion increase. This result shows that the
vanishing of the lag time in 100 mM trehalose is not caused by the
more expanded monolayer on this subphase.
Fig. 6. Potential of mean force (PMF) versus the constrained center-of-mass (COM)
distance of the peptide and the lipid monolayer for water and trehalose subphases.
Fig. 4. Percent area change versus time curves at 30 °C on trehalose subphase at 25 mN/
m and on water subphase at 11 mN/m and 25 mN/m. The area per lipid molecule at
11 mN/m on the water subphase corresponds to that at 25 mN/m on the trehalose
subphase.
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at different trehalose concentrations. The addition of trehalose does
not have a signiﬁcant effect at or below 10 mM concentration. The lag
time is shorter at 50 mM and vanishes at 100 mM trehalose
concentration.
In order to gain more insight into the observed differences in the
insertion process, in particular the disappearance of the lag time and
the decrease in the total amount of peptide insertion, we performed
molecular simulations of the full Aβ(1–40) peptide and DPPG
monolayer system. Fig. 6 shows the potential of mean force versus
the constrained distance of the peptide and monolayer center of
masses in water and trehalose subphases. The total peptide insertion
in equilibrium is proportional to the integral of the Boltzmann factor
of the free energy differences between the bulk and the monolayer
surface. Consistent with our experimental observations, the curve for
the water subphase exhibits a lower free energy minimum in the
monolayer and it is wider, which both contribute to a larger integral
and therefore a larger amount of peptide insertion at equilibrium. The
minima of the PMF curves for the water and trehalose subphases are
at 0.5 nm and 1 nm (center-of-mass COM distances) away from the
monolayer. In pure water, Aβ(1–40) peptide inserts deeper into the
monolayer (closer to the COM of the lipid monolayer) compared to
the trehalose subphase, which could also contribute to a larger area
increase for the water subphase.Fig. 5. Percent area change versus time curves of a DPPG ﬁlm at constant surface
pressure of 25 mN/m and 30 °C after injection of Aβ into 10 mM, 50 mM, 100 mM
trehalose subphases and pure water at time zero.Figs. 7(a) and (b) provide the percent helicity of Aβ(1–40) at each
residue, in the water and trehalose subphases, respectively. The
helicities are given in the bulk and in the monolayer. The monolayer
positions are chosen to correspond to the free energy minima forFig. 7. Percent helicity for each residue of the Aβ(1–40) peptide in the bulk, and
position of the free energy minimum for monolayer insertion in (a) water and
(b) trehalose subphases.
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water and 1 nm for trehalose subphases respectively). These ﬁgures
show that in the bulk and in the monolayer, the peptide adopts a
conformation that comprises a random coil and an alpha-helical
region. Recent NMR studies of the human and rat islet amyloid
polypeptide have shown that these peptides also fold into mixed
random coil and alpha-helical domains in the presence of membranes
[46,59–61].
A comparison of Figs. 7(a) and (b) shows that the peptide needs to
undergo a larger conformational change in order to insert into the
DPPG monolayer in the water subphase compared to the trehalose
subphase. Quantitatively, the root mean square deviation (RMSD) of
the percent helicities during monolayer insertion are 33% and 26% for
the complete peptide in the water and trehalose subphases,
respectively. In particular, for the hydrophobic end of the peptide,
namely Aβ(29–40), which is believed to be largely responsible for
insertion into cell membranes, the RMSDs of helicity changes are 36%
and 20% for the water and trehalose subphases, respectively. These
structural changes observed in simulations help explain why peptide
insertion is easier in the trehalose subphase, and are consistent with
the experimentally observed disappearance of the lag time with
trehalose. Note that the overall helicity of the peptide in the bulk is
26% in water and 30% in trehalose. The increase in the helicity caused
by trehalose is more dramatic in the hydrophobic end region of the
peptide, Aβ(29–40), where trehalose increases the percent helicity
from 25% (in water) to 44%.
It is of interest to analyze the orientation of the helical regions of
the peptide when it is inserting into the monolayer. There are twoFig. 8. (a) The angle between the helix axis and the plane of the monolayer for the two
Representative conﬁgurations of the peptide inserted into the membrane in (b) water and
(VMD) [70].undisturbed helical sections of the peptide for each subphase. These
helical sections are marked on Figs. 7(a) and (b) as “H1” and “H2”.
Section H2 is located close to the hydrophobic C-terminus of the
peptide, which is the endwhere the peptide starts inserting from. This
result is consistent with previous NMR studies that showed that the
amyloid β peptide exhibits two stable α-helical regions in the
presence of negatively charged sodium dodecyl sulfate micelles
[62,63]. Fig. 8(a) gives the angle between the helix axis and the
plane of the monolayer for both of the helices in the water and
trehalose subphases. The empty and ﬁlled symbols represent the ﬁrst
helix, H1, and second helix, H2, respectively. In the water subphase
(circles), the angle is close to zero for both helices. Thismeans that the
helices orient themselves parallel to the surface of the lipid
monolayer. In contrast, in the trehalose subphase (triangles), the
hydrophobic C-terminus of the peptide adopts an average angle of 50°
with respect to the monolayer. The positive sign of the angle indicates
that the residue with the higher residue number, in this case M35, is
closest to the monolayer. The second helix in trehalose makes an
angle of about 20° to the monolayer surface and the negative sign
indicates that the residue K16 is closest to the monolayer for this
helix. The representative structures of the peptide at the monolayer
surface are given in Figs. 8(b) and (c).
5. Discussion
We conducted the peptide insertion experiments at 25 mN/m and
30 mN/m surface pressures of DPPG. The lipid-packing density of a
bilayer is roughly equal to that of a monolayer at around 30 mN/muninterrupted helical sections of Aβ(1–40) in water and trehalose subphases. (b,c)
(c) trehalose subphases. Snapshots were rendered using visual molecular dynamics
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phase of the liquid expanded and condensed phases. Using ﬂuores-
cently dyed lipid and peptide, the amyloid beta peptide has been
shown to insert into the liquid expanded phase parts of the lipid
monolayer [24]. We have chosen to do the experiments with purely
negatively charged DPPG monolayers since amyloid beta peptide has
been shown to interact more readily with negatively charged
membranes [24]. The insertion of the peptide into the monolayer at
these conditions is higher and therefore the effect of trehalose can be
examined more easily.
On the water subphase, the constant-pressure curves exhibit a
sigmoidal shape consisting of a lag time and a growth phase. An
increase in temperature decreases the lag time, and increases the
amount of insertion. There is a discontinuity in the insertion curves
between 30 °C and 25 °C. This is because of a phase transition in
the monolayer between these temperatures. The triple point of the
DPPG monolayer on pure water is 23 °C [64]. Upon compression of
the monolayer, the gas phase ﬁrst transforms into the liquid expan-
ded and then the liquid condensed phase above 23 °C, while it directly
transforms into the liquid condensed phase below 23 °C. The
insertion of the peptide into the monolayer is easier when the
monolayer is in the liquid expanded phase. In pure water, increasing
the surface pressure from 25 mN/m to 30 mN/m reduced the
expansion of the monolayer by approximately a factor of three.
Within the time scale of our experiments, the expansion of the
monolayer in pure water does not reach a saturation, terminal value.
In contrast, if the subphase includes 100 mM trehalose, the lag time
vanishes and the peptide starts inserting immediately after injection
into the subphase. Increasing the surface pressure from 25 mN/m to
30 mN/m causes a 10-fold decrease in the expansion of the
monolayer. The monolayer becomes saturated after approximately
1 h, and the terminal degree of expansion is not particularly sensitive
to temperature.
Results of simulations indicate that more peptide inserts in the
water subphase, and that such insertion is deeper into the monolayer.
Also, in the water subphase, the helical parts of the peptide at the C-
terminus, which is the part that inserts into the monolayer, orients
parallel to the monolayer. In contrast, in the trehalose subphase, the
helical region at the hydrophobic C-terminus of the peptide makes an
angle of 50° to the membrane, and occupies less space. These
observations explain the larger area increase observed in experiments
with a water subphase. Simulations also reveal that, in the water
subphase, the secondary structure of the peptide undergoes consid-
erable conformational changes, especially in the hydrophobic end
region of the molecule. In contrast, such changes are relatively minor
during insertion from the trehalose subphase. Such large conforma-
tional changes in the hydrophobic C-terminus of the peptide (or lack
thereof in the trehalose subphase) help explain why the lag time for
insertion is eliminated by the presence of trehalose. Since such
changes would be faster at higher temperatures, this view of peptide
insertion is also consistent with the experimental observation that the
lag time (in water) decreases with increasing temperature.
Literature reports have argued that sugars are preferentially
excluded from the vicinity of proteins in solution, leading to a
preferential hydration of the proteins that favors a tight globular
conformation [65–67]. We propose that trehalose causes the Amyloid
β peptide to adopt a more α-helical conformation, especially in the
hydrophobic end region, that is more readily inserted into the
monolayer. Our current view is that, in aqueous solution, Aβ peptide
needs to undergo a large change in its secondary structure in order to
insert into the DPPG monolayer. In a trehalose solution, the peptide
rapidly adopts a conﬁguration which is similar to that in the
monolayer, thereby reducing or eliminating the lag time for insertion.
In the water subphase, the peptide can insert deeper into the
monolayer and the free energy proﬁle is broader, leading to larger
peptide insertion and a correspondingly larger area increase.Trehalose causes a dehydration of the lipid molecules; up to half of
the hydrogen bonds between the lipid and water are replaced by
trehalose molecules at concentrations above 20 mM [39,68]. Treha-
lose also decreases the dipole potential of the membrane. These
effects may also be partially responsible for the disappearance of the
lag time at high trehalose concentrations. The effect of trehalose on
monolayers is believed to be comparable to that on bilayers [69]; the
results of the Langmuir monolayer insertion experiments therefore
provide insights into the effect of trehalose on the interaction of Aβ
peptide with lipid vesicles as well.
We end our discussion with a few concluding remarks concerning
the nature of the inserted peptide. In water, the monolayer expands
considerably upon insertion. In trehalose, the extent of expansion is
much more limited, and depends only slightly on temperature.
However, at any given pressure, the monolayer is more expanded to
begin with when trehalose is present. Based on that fact alone (a
monolayer of lesser density), one would naively expect a greater
degree of insertion and expansion in the presence of trehalose. To
reconcile these seemingly contradictory observations, we speculate
that insertion into the trehalose monolayer proceeds in a much more
disorderly manner, with α-helical peptides rapidly inserting into the
monolayer and reaching a dense, jammed state that is reminiscent of
that encountered in amorphous solids, glasses, and colloids. In the
water subphase, insertion proceeds much more gradually, thereby
giving time for themonolayer to rearrange as more peptide is inserted
and eventually absorb a greater amount of peptide, even if its density
is higher.
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